219 results on '"Massimo Primignani"'
Search Results
152. Anticoagulation does not increase portal hypertension related bleeding, but exposes patients with cirrhosis to a high risk of minor hemorrhages: Results from a comparative cohort study
153. Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience
154. Splanchnic Vein Thrombosis Associated with Myeloproliferative Neoplasms: A Study of the AGIMM & IWG-MRT Groups in 519 Subjects
155. Risk factors for thrombophilia in extrahepatic portal vein obstruction
156. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests
157. Unsuspected ileal stenosis causing obscure GI bleeding in patients with previous abdominal surgery--diagnosis by capsule endoscopy: a report of two cases
158. More on: enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy
159. Chronic treatment with betablockers for the management of portal hypertension: A multi-center cross-sectional study in elderly patients with cirrhosis
160. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and could be a modifiable factor to improve prognosis in cirrhosis
161. Portal hypertension but not HCC risk is attenuated in compensated cirrhotics following 10 years of treatment with nucleos(t)ide analogs
162. Splanchnic Vein Thrombosis Associated With Myeloproliferative Neoplasms. A Study Of The IWG-MRT In 475 Subjects
163. Incidence of post-endoscopic retrograde-cholangiopancreatography/sphincterotomy pancreatitis depends upon definition criteria
164. [83] TREATMENT OF BUDD CHIARI SYNDROME WITH TIPS. LONG-TERM RESULTS IN 124 PATIENTS AND EVALUATION OF PROGNOSTIC FACTORS
165. Reply
166. 259 DETERMINANTS OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
167. T-46 Determinants of bleeding from esophageal varices in patients with advanced hepatocellular carcinoma treated with sorafenib
168. Fibrinogen γ' In the Budd-Chiari Syndrome: Results From a Multicenter Case-Control Study
169. JAK2 Germline Genetic Variation In Budd-Chiari Syndrome and Portal Vein Thrombosis
170. Extra-hepatic portal vein obstruction (EHPVO) in adult patients: Role of congenital or acquired thrombophylic disorders as etiologic factors
171. Response: Anticoagulation in splanchnic vein thrombosis
172. S1830 Influence of Portal Vein Thrombosis (PVT) On the Efficacy of Variceal Band Ligation
173. 185 DOES PORTAL VEIN THROMBOSIS IMPACT ON THE EFFICACY OF VARICEAL BAND LIGATION?
174. Influence of portal vein thrombosis (PVT) on the efficacy of variceal band ligation
175. 282 HIGH INCIDENCE OF HEPARIN INDUCED THROMBOCYTOPENIA (HIT) IN SPLANCHNIC VEIN THROMBOSIS TREATED WITH LOW MOLECULAR WEIGHT HEPARIN (LMWH)
176. High incidence of heparin-induced thrombocytopaenia (HIT) in splanchnic vein thrombosis treated with low molecular weight heparin (LMWH)
177. [3] A PROSPECTIVE FOLLOW-UP STUDY ON 163 PATIENTS WITH BUDD-CHIARI SYNDROME: RESULTS FROM THE EUROPEAN NETWORK FOR VASCULAR DISORDERS OF THE LIVER (EN-VIE)
178. Tips in Budd Chiari Syndrome: Long-term results in 124 patients and evaluation of prognostic factors
179. 69 Local circulation of VEGF is involved in collateral vessels development in cirrhotic patients with portal hypertension
180. 215 Efficiency of current guidelines for primary prevention of variceal bleeding in cirrhosis
181. 212 Prognostic value of a single hepatic venous pressure gradient measurement in cirrhotic patients
182. Risk factors of death in variceal bleeding: Combined effect of thrombin activatable fibrinolysis inhibitor (TAFI) deficiency and Child-Pugh C class
183. 5 P Thrombin activatable fibrinolysis inhibitor (TAFI) deficiency is an independent prognostic factor of death from variceal bleeding in cirrhosis of the liver
184. 35 P Successful identification of a jejunal dieulafoy lesion by wireless capsule enteroscopy: A case report
185. 32 P Successful diagnosing of a gastrointestinal stromal tumor (GIST) by wireless capsule enteroscopy in a patient with a history of obscure gastrointestinal bleeding: A case report
186. 33 P Asymptomatic ileal stenosis with pre-stenotic mucosal ulcer causing obscure GI bleeding in patients with previous abdominal surgery — diagnosis by wireless capsule enteroscopy: A report of two cases
187. 2 OP Use of the given® video capsule system in small bowel transplanted patients
188. Presence of esophageal varices in patients with a recent histoligic diagnosis of cirrhosis of the liver: evaluation of clinical predictors
189. Post-ERCP pancreatitis is reliably foretold by hyperamylasemia greater than five times the upper normal limit associated with 24-hour pancreatic-like pain
190. Fibrinolytic and hemostatic abnormalities in gastro-esophageal variceal bleeding in cirrhotic patients
191. Natural history of extra-hepatic portal vein obstruction (EHPVO) in western countries
192. Fibrinolytic and hemostatic abnormalities in gastroesophageal varicealbleeding in cirrhotic patients
193. Does endoscopic treatment of esophageal varices, with sclerotherapy (ES) or ligation (EL), influence the evolution of portal hypertensive gastropathy (PHG) in cirrhotic patients?
194. ‘De novo’ development of esophageal varices in patients with a recent histologic diagnosis of liver cirrhosis
195. Prevention of variceal bleeding with band ligation
196. Endoscopic Diagnosis and Classification of Varices
197. The Role of Thrombophilia in Splanchnic Vein Thrombosis.
198. Development of simplified prognostic index to predict the first esophageal bleed in cirrhotics
199. Prognosis of advanced liver cirrhosis: A model to help selecting patients for liver transplantation
200. Diagnostic value of serum cholylglycine radioimmunoassay in chronic asymptomatic HBsAg carriers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.